A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function

PLoS Genetics

Volumn 9, Issue 2, 2013, Pages

  Porcu, Eleonora ^a,b   Medici, Marco ^c   Pistis, Giorgio ^a,b,d,e   Volpato, Claudia B ^f,aw   Wilson, Scott G ^g,h,i   Cappola, Anne R ^j   Bos, Steffan D ^k,l   Deelen, Joris ^k,l   den Heijer, Martin ^m,n   Freathy, Rachel M ^o   Lahti, Jari ^p   Liu, Chunyu ^q   Lopez, Lorna M ^r   Nolte, Ilja M ^s   O'Connell, Jeffrey R ^t   Tanaka, Toshiko ^u   Trompet, Stella ^k   Arnold, Alice ^v   Bandinelli, Stefania ^w   Beekman, Marian ^k,l   Böhringer, Stefan ^k   Brown, Suzanne J ^g   Buckley, Brendan M ^x   Camaschella, Clara ^d,y   de Craen, Anton J M ^k   Davies, Gail ^r   de Visser, Marieke C H ^m   Ford, Ian ^z   Forsen, Tom ^p,aa,ab,ac   Frayling, Timothy M ^o   Fugazzola, Laura ^ad   Gögele, Martin ^f   Hattersley, Andrew T ^o   Hermus, Ad R ^m   Hofman, Albert ^c,ae   Houwing Duistermaat, Jeanine J ^k   Jensen, Richard A ^v   Kajantie, Eero ^aa,af   Kloppenburg, Margreet ^k   Lim, Ee M ^g,ag   Masciullo, Corrado ^d   Mariotti, Stefano ^ah   Minelli, Cosetta ^f   Mitchell, Braxton D ^t   Nagaraja, Ramaiah ^u   Netea Maier, Romana T ^m   Palotie, Aarno ^p,ab,ai   Persani, Luca ^ad,aj   Piras, Maria G ^a   Psaty, Bruce M ^v,ak   Räikkönen, Katri ^p   Richards, J Brent ^h,al,am   Rivadeneira, Fernando ^c,ae   Sala, Cinzia ^d   Sabra, Mona M ^an   Sattar, Naveed ^ao   Shields, Beverley M ^o   Soranzo, Nicole ^ai   Starr, John M ^r   Stott, David J ^z   Sweep, Fred C G J ^m   Usala, Gianluca ^a   van der Klauw, Melanie M ^s   van Heemst, Diana ^k   van Mullem, Alies ^c   H Vermeulen, Sita ^m   Visser, W Edward ^c   Walsh, John P ^g,i   Westendorp, Rudi G J ^k   Widen, Elisabeth ^p   Zhai, Guangju ^h,ap   Cucca, Francesco ^a,b   Deary, Ian J ^r   Eriksson, Johan G ^{p,aa,ab,aq,ar}   Ferrucci, Luigi ^u   Fox, Caroline S ^q,as   Jukema, J Wouter ^k,at,au   Kiemeney, Lambertus A ^m   Pramstaller, Peter P ^f,av,aw   Schlessinger, David ^u   Shuldiner, Alan R ^t,ax   Slagboom, Eline P ^k,l   Uitterlinden, André G ^c,ae   Vaidya, Bijay ^ay   Visser, Theo J ^c   Wolffenbuttel, Bruce H R ^s   Meulenbelt, Ingrid ^k,l   Rotter, Jerome I ^az   Spector, Tim D ^h   Hicks, Andrew A ^f   Toniolo, Daniela ^d,ba   Sanna, Serena ^a   Peeters, Robin P ^c   Naitza, Silvia ^a   more..

^a Milan Unit   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

^f University of Lubeck   (Italy)

^g SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^l Netherlands Consortium for Healthy Ageing   (Netherlands)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^o UNIVERSITY OF EXETER   (United Kingdom)

^p UNIVERSITY OF HELSINKI   (Finland)

^q NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^r UNIVERSITY OF EDINBURGH   (United Kingdom)

^s UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^t UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^u NATIONAL INSTITUTE ON AGING   (United States)

^v UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^w Azienda Sanitaria di Firenze   (Italy)

^x UNIVERSITY COLLEGE CORK   (Ireland)

^y VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^z UNIVERSITY OF GLASGOW   (United Kingdom)

^aa NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ab HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ac Vaasa Health Care Centre   (Finland)

^ad UNIVERSITY OF MILAN   (Italy)

^ae Netherlands Genomics Initiative   (Netherlands)

^af HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ag PATHWEST LABORATORY MEDICINE   (Australia)

^ah UNIVERSITY OF CAGLIARI   (Italy)

^ai WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^aj IRCCS   (Italy)

^ak CENTER FOR HEALTH STUDIES   (United States)

^al MCGILL UNIVERSITY   (Canada)

^am MCGILL UNIVERSITY   (Canada)

^an MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ao UNIVERSITY OF GLASGOW   (United Kingdom)

^ap MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^aq FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ar VAASA CENTRAL HOSPITAL   (Finland)

^as BRIGHAM AND WOMEN S HOSPITAL   (United States)

^at Durrer Center for Cardiogenetic Research   (Netherlands)

^au ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^av General Central Hospital   (Italy)

^aw UNIVERSITY OF LÜBECK   (Germany)

^ax BALTIMORE VA MEDICAL CENTER   (United States)

^ay ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^az CEDARS SINAI MEDICAL CENTER   (United States)

^ba CNR   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

AADAT GENE; ABO GENE; ARTICLE; CAPN52 GENE; EUTHYROIDISM; FBXO15 GENE; FEEDBACK SYSTEM; FGF7 GENE; FOXE1 GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GLIS3 GENE; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; IGFBP5 GENE; INSR GENE; ITPK1 GENE; LHX3 GENE; LPCAT2 GENE; MAF GENE; MBIP GENE; MIR1179 GENE; NETO1 GENE; NFIA GENE; NRG1 GENE; PDE10A GENE; PDE88 GENE; PRDM11 GENE; SASH1 GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOX9 GENE; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VEGFA GENE;

FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 84874781557     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003266     Document Type: Article

References (85)

1. Toft AD, (2001) Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345: 512-516.
2. Cooper DS, (2001) Clinical practice. Subclinical hypothyroidism. N Engl J Med 345: 260-265.
3. Fernandez-Real JM, Lopez-Bermejo A, Castro A, Casamitjana R, Ricart W, (2006) Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 91: 3337-3343.
4. Biondi B, Cooper DS, (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29: 76-131.
5. Chiamolera MI, Wondisford FE, (2009) Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150: 1091-1096.
6. Andersen S, Pedersen KM, Bruun NH, Laurberg P, (2002) Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87: 1068-1072.
7. Bulow Pedersen I, Knudsen N, Jorgensen T, Perrild H, Ovesen L, et al. (2002) Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab 87: 4462-4469.
8. Franklyn JA, Ramsden DB, Sheppard MC, (1985) The influence of age and sex on tests of thyroid function. Ann Clin Biochem 22 (Pt 5) (): 502-505.
9. Bartalena L, Bogazzi F, Brogioni S, Burelli A, Scarcello G, et al. (1996) Measurement of serum free thyroid hormone concentrations: an essential tool for the diagnosis of thyroid dysfunction. Horm Res 45: 142-147.
10. Hansen PS, Brix TH, Sorensen TI, Kyvik KO, Hegedus L, (2004) Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J Clin Endocrinol Metab 89: 1181-1187.
11. Samollow PB, Perez G, Kammerer CM, Finegold D, Zwartjes PW, et al. (2004) Genetic and environmental influences on thyroid hormone variation in Mexican Americans. J Clin Endocrinol Metab 89: 3276-3284.
12. Panicker V, Wilson SG, Spector TD, Brown SJ, Falchi M, et al. (2008) Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort. Clin Endocrinol (Oxf) 68: 652-659.
13. Arnaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, et al. (2008) Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 82: 1270-1280.
14. Panicker V, Wilson SG, Walsh JP, Richards JB, Brown SJ, et al. (2010) A locus on chromosome 1p36 is associated with thyrotropin and thyroid function as identified by genome-wide association study. Am J Hum Genet 87: 430-435.
15. Rawal R, Teumer A, Volzke H, Wallaschofski H, Ittermann T, et al. (2012) Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function. Hum Mol Genet.
16. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, et al. (2003) Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88: 2880-2888.
17. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, et al. (2008) A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab 93: 3075-3081.
18. Medici M, van der Deure WM, Verbiest M, Vermeulen SH, Hansen PS, et al. (2011) A large-scale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels. Eur J Endocrinol 164: 781-788.
19. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, et al. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41: 460-464.
20. Denny JC, Crawford DC, Ritchie MD, Bielinski SJ, Basford MA, et al. (2011) Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet 89: 529-542.
21. Boucai L, Hollowell JG, Surks MI, (2011) An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 21: 5-11.
22. McGrogan A, Seaman HE, Wright JW, de Vries CS, (2008) The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf) 69: 687-696.
23. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, et al. (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489-499.
24. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.
25. Ben-Aharon I, Brown PR, Etkovitz N, Eddy EM, Shalgi R, (2005) The expression of calpain 1 and calpain 2 in spermatogenic cells and spermatozoa of the mouse. Reproduction 129: 435-442.
26. Pilia G, Chen WM, Scuteri A, Orru M, Albai G, et al. (2006) Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet 2: e132 doi:10.1371/journal.pgen.0020132.
27. Shields BM, Freathy RM, Knight BA, Hill A, Weedon MN, et al. (2009) Phosphodiesterase 8B gene polymorphism is associated with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab 94: 4608-4612.
28. Montero-Pedrazuela A, Fernandez-Lamo I, Alieva M, Pereda-Perez I, Venero C, et al. (2011) Adult-onset hypothyroidism enhances fear memory and upregulates mineralocorticoid and glucocorticoid receptors in the amygdala. PLoS ONE 6: e26582 doi:10.1371/journal.pone.0026582.
29. Eriksson N, Tung JY, Kiefer AK, Hinds DA, Francke U, et al. (2012) Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci. PLoS ONE 7: e34442 doi:10.1371/journal.pone.0034442.
30. Sheng HZ, Zhadanov AB, Mosinger B Jr, Fujii T, Bertuzzi S, et al. (1996) Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 272: 1004-1007.
31. Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, et al. (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 25: 182-186.
32. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, et al. (2012) Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 44: 319-322.
33. Taylor PN, Panicker V, Sayers A, Shields B, Iqbal A, et al. (2011) A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement. Eur J Endocrinol 164: 773-780.
34. Volpato CB, De Grandi A, Gogele M, Taliun D, Fuchsberger C, et al. (2011) Linkage and association analysis of hyperthyrotropinaemia in an Alpine population reveal two novel loci on chromosomes 3q28-29 and 6q26-27. J Med Genet 48: 549-556.
35. Kitazawa M, Yamakuni T, Song SY, Kato C, Tsuchiya R, et al. (2005) Intracellular cAMP controls a physical association of V-1 with CapZ in cultured mammalian endocrine cells. Biochem Biophys Res Commun 331: 181-186.
36. Teumer A, Rawal R, Homuth G, Ernst F, Heier M, et al. (2011) Genome-wide association study identifies four genetic loci associated with thyroid volume and goiter risk. Am J Hum Genet 88: 664-673.
37. Duan C, Clemmons DR, (1995) Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem 270: 24844-24851.
38. de Jong FJ, Peeters RP, den Heijer T, van der Deure WM, Hofman A, et al. (2007) The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92: 636-640.
39. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, et al. (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29: 898-938.
40. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, et al. (1998) A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 19: 395-398.
41. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, et al. (1998) Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 19: 399-401.
42. Pfaeffle RW, Savage JJ, Hunter CS, Palme C, Ahlmann M, et al. (2007) Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. J Clin Endocrinol Metab 92: 1909-1919.
43. Rajab A, Kelberman D, de Castro SC, Biebermann H, Shaikh H, et al. (2008) Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Hum Mol Genet 17: 2150-2159.
44. Okada Y, Kamatani Y, Takahashi A, Matsuda K, Hosono N, et al. (2010) A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum Mol Genet 19: 2303-2312.
45. Helmreich DL, Parfitt DB, Lu XY, Akil H, Watson SJ, (2005) Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress. Neuroendocrinology 81: 183-192.
46. Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L, (2009) The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci 283: 21-27.
47. Goh DL, Patel A, Thomas GH, Salomons GS, Schor DS, et al. (2002) Characterization of the human gene encoding alpha-aminoadipate aminotransferase (AADAT). Mol Genet Metab 76: 172-180.
48. de Souza FR, Fontes FL, da Silva TA, Coutinho LG, Leib SL, et al. (2010) Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis. BMC Med Genet 12: 51.
49. Han Q, Cai T, Tagle DA, Li J, (2009) Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci 67: 353-368.
50. Segrè AV, Groop L, Mootha VK, Daly MJ, Altshuler D, (2010) Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 6: e1001058 doi:10.1371/journal.pgen.1001058.
51. Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, Purcell SM, et al. (2009) Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet 5: e1000534 doi:10.1371/journal.pgen.1000534.
52. Senee V, Chelala C, Duchatelet S, Feng D, Blanc H, et al. (2006) Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 38: 682-687.
53. Salajegheh A, Smith RA, Kasem K, Gopalan V, Nassiri MR, et al. (2011) Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes. Eur J Surg Oncol 37: 93-99.
54. Stolf BS, Carvalho AF, Martins WK, Runza FB, Brun M, et al. (2003) Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Cancer Lett 191: 193-202.
55. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, et al. (2002) A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87: 245-254.
56. Braunschweig T, Kaserer K, Chung JY, Bilke S, Krizman D, et al. (2007) Proteomic expression profiling of thyroid neoplasms. Proteomics Clin Appl 1: 264-271.
57. Willer CJ, Li Y, Abecasis GR, (2010) METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26: 2190-2191.
58. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR, (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816-834.
59. Marchini J, Howie B, Myers S, McVean G, Donnelly P, (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39: 906-913.
60. Howie BN, Donnelly P, Marchini J, (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529 doi:10.1371/journal.pgen.1000529.
61. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.
62. Klein M, Catargi B, (2007) VEGF in physiological process and thyroid disease. Ann Endocrinol (Paris) 68: 438-448.
63. Gerard AC, Poncin S, Caetano B, Sonveaux P, Audinot JN, et al. (2008) Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am J Pathol 172: 748-760.
64. Yamada E, Yamazaki K, Takano K, Obara T, Sato K, (2006) Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors. Thyroid 16: 545-554.
65. Zhang L, Cooper-Kuhn CM, Nannmark U, Blomgren K, Kuhn HG, (2010) Stimulatory effects of thyroid hormone on brain angiogenesis in vivo and in vitro. J Cereb Blood Flow Metab 30: 323-335.
66. Yu H, Rohan T, (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92: 1472-1489.
67. Eggo MC, King WJ, Black EG, Sheppard MC, (1996) Functional human thyroid cells and their insulin-like growth factor-binding proteins: regulation by thyrotropin, cyclic 3′,5′ adenosine monophosphate, and growth factors. J Clin Endocrinol Metab 81: 3056-3062.
68. Backeljauw PF, Dai Z, Clemmons DR, D'Ercole AJ, (1993) Synthesis and regulation of insulin-like growth factor binding protein-5 in FRTL-5 cells. Endocrinology 132: 1677-1681.
69. Pepene CE, Kasperk CH, Pfeilschifter J, Borcsok I, Gozariu L, et al. (2001) Effects of triiodothyronine on the insulin-like growth factor system in primary human osteoblastic cells in vitro. Bone 29: 540-546.
70. Zhou R, Bonneaud N, Yuan CX, de Santa Barbara P, Boizet B, et al. (2002) SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res 30: 3245-3252.
71. das Neves L, Duchala CS, Tolentino-Silva F, Haxhiu MA, Colmenares C, et al. (1999) Disruption of the murine nuclear factor I-A gene (Nfia) results in perinatal lethality, hydrocephalus, and agenesis of the corpus callosum. Proc Natl Acad Sci U S A 96: 11946-11951.
72. Nakazato M, Chung HK, Ulianich L, Grassadonia A, Suzuki K, et al. (2000) Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression. Mol Cell Biol 20: 8499-8512.
73. Moeller LC, Kimura S, Kusakabe T, Liao XH, Van Sande J, et al. (2003) Hypothyroidism in thyroid transcription factor 1 haploinsufficiency is caused by reduced expression of the thyroid-stimulating hormone receptor. Mol Endocrinol 17: 2295-2302.
74. Revest JM, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I, et al. (2001) Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol 231: 47-62.
75. Jiang GL, Huang S, (2000) The yin-yang of PR-domain family genes in tumorigenesis. Histol Histopathol 15: 109-117.
76. Naitza S, Porcu E, Steri M, Taub DD, Mulas A, et al. (2012) A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet 8: e1002480 doi:10.1371/journal.pgen.1002480.
77. Carmel R, Spencer CA, (1982) Clinical and subclinical thyroid disorders associated with pernicious anemia. Observations on abnormal thyroid-stimulating hormone levels and on a possible association of blood group O with hyperthyroidism. Arch Intern Med 142: 1465-1469.
78. Majerus PW, Wilson DB, Zhang C, Nicholas PJ, Wilson MP, (2010) Expression of inositol 1,3,4-trisphosphate 5/6-kinase (ITPK1) and its role in neural tube defects. Adv Enzyme Regul 50: 365-372.
79. Grasberger H, Van Sande J, Hag-Dahood Mahameed A, Tenenbaum-Rakover Y, Refetoff S, (2007) A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis. J Clin Endocrinol Metab 92: 2816-2820.
80. Fukuyama K, Yoshida M, Yamashita A, Deyama T, Baba M, et al. (2000) MAPK upstream kinase (MUK)-binding inhibitory protein, a negative regulator of MUK/dual leucine zipper-bearing kinase/leucine zipper protein kinase. J Biol Chem 275: 21247-21254.
81. Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, et al. (2012) The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci U S A 109: 8646-8651.
82. Dubois F, Vandermoere F, Gernez A, Murphy J, Toth R, et al. (2009) Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling. Mol Cell Proteomics 8: 2487-2499.
83. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19: 2516-2523.
84. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, et al. (2009) The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5: e1000637 doi:10.1371/journal.pgen.1000637.
85. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, et al. (2010) The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19: 2516-2523.